Engaging the OR and Procedural Areas to Mitigate Risks with Controlled Substance Medications
Workflow processes in ORs and procedural areas can contribute to an environment vulnerable to drug diversion. Broad access to a variety of medications, delays in documentation, rapid patient turn over and limited practitioner oversight makes detectability difficult.
Learn how to engage professionals in implementing best practices in the OR and procedural areas for controlled substance management. Faculty will illustrate how through leadership and collaboration, organizations have implemented safeguards and create a culture of awareness and accountability in all levels of the organization, providing effective drug diversion prevention and response.
Medication Safety and Patient Safety Officers
Risk Management and Quality Managers
Medication Safety Committees
Following completion of this activity, participants will be able to:
Cite the scope and impact of diversion issues within OR and procedural areas.
Apply two interventions to minimize diversion of controlled substances in the OR and procedural areas.
Engage key stakeholders in waste reduction through the implementation of a diversion management plan.
Ryan Haumschild, PharmD, MS, MBA, Director of Pharmacy, Emory Healthcare, ISMP Advisory Board
Edward Pollak, MD, Anesthesiologist, Chief Quality Officer, Henry Ford Hospital
This activity is funded by Fresenius Kabi.
No continuing education credits are available for this activity.